tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BYSI Stock Latest News

BeyondSpring’s 2024 Progress and Strategic Milestones
Company AnnouncementsBeyondSpring’s 2024 Progress and Strategic Milestones
13d ago
BYSI
BeyondSpring reports FY24 EPS (21c) vs. (34c) last year
PremiumThe Fly
BeyondSpring reports FY24 EPS (21c) vs. (34c) last year
14d ago
BYSI
BeyondSpring announces expected 2025 milestones
PremiumThe Fly
BeyondSpring announces expected 2025 milestones
14d ago
BYSI
SEED receives FDA Rare Pediatric Disease, Orphan Drug designations for ST-01156
PremiumThe Fly
SEED receives FDA Rare Pediatric Disease, Orphan Drug designations for ST-01156
2M ago
BYSI
BeyondSpring to sell portion of equity interest in SEED for $35.4MEli Lilly
PremiumThe Fly
BeyondSpring to sell portion of equity interest in SEED for $35.4MEli Lilly
2M ago
LLY
BYSI
BeyondSpring presents efficacy results from Phase 2 IIT study of plinabulin
PremiumThe FlyBeyondSpring presents efficacy results from Phase 2 IIT study of plinabulin
5M ago
BYSI
BeyondSpring presents final data analysis of DUBLIN-3 Phase 3 study
Premium
The Fly
BeyondSpring presents final data analysis of DUBLIN-3 Phase 3 study
7M ago
BYSI
BeyondSpring presented interim Phase 2 data on 303 Study
Premium
The Fly
BeyondSpring presented interim Phase 2 data on 303 Study
7M ago
MRK
BYSI
BeyondSpring announces Dublin-3 final phase 3 efficacy data
PremiumThe Fly
BeyondSpring announces Dublin-3 final phase 3 efficacy data
7M ago
BYSI
BeyondSpring Inc. Reports Mid-Year Financials
PremiumCompany Announcements
BeyondSpring Inc. Reports Mid-Year Financials
7M ago
6K
BYSI
SEED and Eisai Partner on Groundbreaking Biotech Research
PremiumCompany Announcements
SEED and Eisai Partner on Groundbreaking Biotech Research
8M ago
6K
BYSI
SEED Therapeutics enters strategic research collab with Eisai
PremiumThe Fly
SEED Therapeutics enters strategic research collab with Eisai
8M ago
BYSI
BeyondSpring files to sell 10M ordinary shares
PremiumThe FlyBeyondSpring files to sell 10M ordinary shares
10M ago
BYSI
BeyondSpring Inc. Announces Share Issuance
Premium
Company Announcements
BeyondSpring Inc. Announces Share Issuance
10M ago
6K
BYSI
BeyondSpring announces R&D day on new Plinabulin strategy
Premium
The Fly
BeyondSpring announces R&D day on new Plinabulin strategy
11M ago
BYSI
BeyondSpring reports first patient dosed with pembrolizumab, plinabulin plus EP
PremiumThe Fly
BeyondSpring reports first patient dosed with pembrolizumab, plinabulin plus EP
1y ago
BYSI
BeyondSpring Announces Executive Leadership Change
PremiumCompany Announcements
BeyondSpring Announces Executive Leadership Change
1y ago
6K
BYSI
BeyondSpring regains compliance with Nasdaq minimum bid price rule
PremiumThe Fly
BeyondSpring regains compliance with Nasdaq minimum bid price rule
1y ago
BYSI
BeyondSpring reports Nasdaq delinquency notice for late filing
PremiumThe Fly
BeyondSpring reports Nasdaq delinquency notice for late filing
1y ago
BYSI
BeyondSpring receives noncompliance notification from Nasdaq
PremiumThe FlyBeyondSpring receives noncompliance notification from Nasdaq
1y ago
BYSI
BeyondSpring presents new data on plinabulin’s immunomodulating activity
Premium
The Fly
BeyondSpring presents new data on plinabulin’s immunomodulating activity
1y ago
BYSI
BeyondSpring presents poster on plinabulin’s anti-cancer efficacy
Premium
The Fly
BeyondSpring presents poster on plinabulin’s anti-cancer efficacy
1y ago
BYSI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >